Sign in to view content

Randomized Trial of Initiating Therapy With Aflibercept, Laser, or Observation for Eyes With Good Vision and Center-Involved DME

Carl W. Baker, MD, FASRS

Video
Published 2019

Carl W. Baker, MD

Diabetic Retinopathy Part I Symposium

Related

Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019
The Functional Burden of Diabetic Retinopathy in the United States – How Ranibizumab May Shift Treatment Paradigms
Jeffrey R Willis, MD/PhD
On Demand Cases, Courses, and Papers
2017
Previous Intravitreal Therapy is Associated With Increased Risk of Posterior Capsule Rupture During Cataract Surgery
Aaron Y Lee, MD, MSCI
Updates from the Field
2016

Category: Diabetic Retinopathy

See more